[In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland].
In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/CSI by the health insurance in Switzerland The reimbursement of certain infertility treatments (stimulation with/without insemination) whereas IVF/ICSI is not leads patients with an indication of IVF to prefer treatments of low efficacy. The costs of multiple pregnancies issued by reimbursed or non-reimbursed fertility treatments are paid by the society. There should be measures to reduce these costs and to take the money used today to pay the complications of infertility treatments to reimburse IVF. The efficacy of such a system (single embryo transfer) has been proven in Belgium since several years. The dangers of complete reimbursement (IVF treatment in cases without any chances of success, only because it is for free) can be avoided by an Efficacy and Safety Board.
Wunder-Galié
D
D
Département de gynécologie-obstétrique, CHUV, Lausanne. dorothea.wunder-galie@chuv.ch
Hohlfeld
P
P
de Ziegler
D
D
D005307:Fertilization in Vitro / Q000191:economics*; D006801:Humans; D019458:Insurance Coverage; D012051:Reimbursement Mechanisms; D027724:Reproductive Techniques, Assisted / Q000191:economics; D013557:Switzerland